These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 19008718

  • 1. Telmisartan improves insulin resistance in high renin nonmodulating salt-sensitive hypertensives.
    Sanchez RA, Masnatta LD, Pesiney C, Fischer P, Ramirez AJ.
    J Hypertens; 2008 Dec; 26(12):2393-8. PubMed ID: 19008718
    [Abstract] [Full Text] [Related]

  • 2. Vascular oxidative stress is associated with insulin resistance in hyper-reninemic nonmodulating essential hypertension.
    Sanchez R, Fischer P, Cuniberti L, Masnatta LD, Ramírez AJ.
    J Hypertens; 2007 Dec; 25(12):2434-40. PubMed ID: 17984665
    [Abstract] [Full Text] [Related]

  • 3. Parallel renal and extremity blood supply abnormalities in nonmodulation: responses to ACE inhibition.
    Sánchez RA, Ramos F, Giannone C, Fischer P, Masnatta L, Baglivo HP, Ramírez AJ, Hollenberg NK.
    Hypertension; 2003 Apr; 41(4):919-24. PubMed ID: 12642507
    [Abstract] [Full Text] [Related]

  • 4. Acute regulation of pancreatic islet microcirculation and glycaemia by telmisartan and ramipril: discordant effects between normal and type 2 diabetic rats.
    Olverling A, Huang Z, Nyström T, Sjöholm Å.
    Clin Sci (Lond); 2013 Nov; 125(9):433-8. PubMed ID: 23713675
    [Abstract] [Full Text] [Related]

  • 5. Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients.
    Vecchiet J, Ucciferri C, Falasca K, Mancino P, Di Iorio A, De Caterina R.
    Antivir Ther; 2011 Nov; 16(5):639-45. PubMed ID: 21817185
    [Abstract] [Full Text] [Related]

  • 6. Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension.
    Benndorf RA, Rudolph T, Appel D, Schwedhelm E, Maas R, Schulze F, Silberhorn E, Böger RH.
    Metabolism; 2006 Sep; 55(9):1159-64. PubMed ID: 16919533
    [Abstract] [Full Text] [Related]

  • 7. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
    Ucciferri C, Falasca K, Mancino P, Di Iorio A, Vecchiet J.
    Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876
    [Abstract] [Full Text] [Related]

  • 8. Telmisartan treatment decreases visceral fat accumulation and improves serum levels of adiponectin and vascular inflammation markers in Japanese hypertensive patients.
    Chujo D, Yagi K, Asano A, Muramoto H, Sakai S, Ohnishi A, Shintaku-Kubota M, Mabuchi H, Yamagishi M, Kobayashi J.
    Hypertens Res; 2007 Dec; 30(12):1205-10. PubMed ID: 18344626
    [Abstract] [Full Text] [Related]

  • 9. Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients.
    Fogari R, Zoppi A, Ferrari I, Mugellini A, Preti P, Lazzari P, Derosa G.
    Horm Metab Res; 2009 Dec; 41(12):893-8. PubMed ID: 19708000
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.
    Rizos CV, Milionis HJ, Kostapanos MS, Florentin M, Kostara CE, Elisaf MS, Liberopoulos EN.
    Clin Ther; 2010 Mar; 32(3):492-505. PubMed ID: 20399986
    [Abstract] [Full Text] [Related]

  • 12. Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.
    Lamarre-Cliche M, de Champlain J, Lacourcière Y, Poirier L, Karas M, Larochelle P.
    Am J Hypertens; 2005 Jan; 18(1):56-64. PubMed ID: 15691618
    [Abstract] [Full Text] [Related]

  • 13. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
    Satoh M, Tabuchi T, Minami Y, Takahashi Y, Itoh T, Nakamura M.
    Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
    [Abstract] [Full Text] [Related]

  • 14. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
    Kobayashi N, Ohno T, Yoshida K, Fukushima H, Mamada Y, Nomura M, Hirata H, Machida Y, Shinoda M, Suzuki N, Matsuoka H.
    Am J Hypertens; 2008 May; 21(5):576-81. PubMed ID: 18437150
    [Abstract] [Full Text] [Related]

  • 15. Role of insulin-sensitizing property of telmisartan, a commercially available angiotensin II type 1 receptor blocker in preventing the development of atrial fibrillation.
    Yamagishi S, Takenaka K, Inoue H.
    Med Hypotheses; 2006 May; 66(1):118-20. PubMed ID: 16154710
    [Abstract] [Full Text] [Related]

  • 16. A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.
    Yang Y, Wei RB, Xing Y, Tang L, Zheng XY, Wang ZC, Gao YW, Li MX, Chen XM.
    Metabolism; 2013 Dec; 62(12):1858-66. PubMed ID: 24050270
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE).
    Mori Y, Tanaka T, Matsuura K, Yokoyama J, Utsunomiya K.
    Adv Ther; 2011 Aug; 28(8):698-706. PubMed ID: 21744143
    [Abstract] [Full Text] [Related]

  • 19. Effects of telmisartan vs olmesartan on metabolic parameters, insulin resistance and adipocytokines in hypertensive obese patients.
    de Luis DA, Conde R, González-Sagrado M, Aller R, Izaola O, Dueñas A, Pérez Castrillón JL, Romero E.
    Nutr Hosp; 2010 Aug; 25(2):275-9. PubMed ID: 20449538
    [Abstract] [Full Text] [Related]

  • 20. Telmisartan lowers home blood pressure and improves insulin resistance without correlation between their changes.
    Kobayashi K, Ohno Y, Takenaka T, Ikeda N, Okada H, Kanno Y, Suzuki H.
    Clin Exp Hypertens; 2011 Aug; 33(2):100-5. PubMed ID: 21269058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.